An official website of the United States government

Here's how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

COVID-19

Expand for resources

PAR-24-064 - Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health	NOT-OD-24-146	OBSSR , NCCIH , NCI , NEI , NHLBI , NIA , NIDA , NIMH , NIMHD , NINR , OAR , ODP , ORWH , SGMRO	Jun 24, 2024	Jul 14, 2027	P01, P30, R01, R03, UG3/UH3, R34, U24, R41/R42, R21, R43/R44, R21/R33, R61

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Developing Digital Therapeutics for Substance Use Disorders	NOT-DA-22-056	NIDA	Feb 18, 2022	Dec 7, 2023	UG3/UH3